Centene beats third quarter 2026 estimates and raises full-year adjusted EPS guidance floor to $5.20

Centene reported third quarter 2026 revenue of $50.6 billion and adjusted EPS of $0.58, significantly outperforming analyst expectations. The company raised its full-year 2026 adjusted EPS guidance floor to greater than $5.20 and improved its expected consolidated HBR midpoint to 90.75%.

Key Highlights

• Total revenues reached $50.6 billion, supported by premium yield growth in the PDP business and Medicaid rate increases to address medical trends.
• Consolidated Health Benefits Ratio (HBR) remained flat year-over-year at 92.7%, benefiting from strong performance in Medicare and Marketplace segments.
• Medicaid membership declined to 11.9 million from 12.7 million in the prior year, primarily due to the impact of redeterminations.
• The company reduced debt by $1.1 billion since June 30, 2026, including the full redemption of its 2027 Senior Notes.